Literature DB >> 15249743

Aberrant serum adiponectin levels in women with uterine leiomyomas.

Hung-Sheng Chen1, Te-Fu Chan, Yueh-Fang Chung, Jinu-Huang Su, Shyng-Shiou F Yuan.   

Abstract

BACKGROUND: Adiponectin is an adipocyte-secreted hormone. Serum adiponectin levels are inversely correlated with insulin resistance, and low plasma adiponectin levels have been demonstrated in type 2 diabetic patients. However, information on serum adiponectin levels in gynecological disorders is mostly lacking. In this study, we analyzed the possible correlation between serum adiponectin levels and uterine leiomyomas.
METHODS: Serum adiponectin levels, determined by radioimmunoassay, were compared in women with uterine leiomyomas (n = 47) and normal controls (n = 46).
RESULTS: Serum adiponectin levels in women with uterine leiomyomas (16.4 +/- 0.9 microg/ml) were significantly lower (p < 0.05) than those in the normal controls (19.5 +/- 1.0 microg/ml). Furthermore, there was an inverse correlation between serum adiponectin levels and body mass index, in both women with leiomyomas and normal controls.
CONCLUSIONS: Serum adiponectin levels are significantly decreased in myomatous patients. Copyright (c) 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249743     DOI: 10.1159/000079553

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  5 in total

Review 1.  The role of adiponectin in reproduction: from polycystic ovary syndrome to assisted reproduction.

Authors:  Konstantinos G Michalakis; James H Segars
Journal:  Fertil Steril       Date:  2010-06-19       Impact factor: 7.329

Review 2.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

Review 3.  Cardiometabolic Risk Factors and Benign Gynecologic Disorders.

Authors:  Abdelrahman AlAshqar; Kristin Patzkowsky; Sadia Afrin; Robert Wild; Hugh S Taylor; Mostafa A Borahay
Journal:  Obstet Gynecol Surv       Date:  2019-11       Impact factor: 2.347

Review 4.  The Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated Symptomatology.

Authors:  Nick Dalton-Brewer
Journal:  Curr Obstet Gynecol Rep       Date:  2016-04-25

5.  Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients.

Authors:  Chin-Hsiao Tseng
Journal:  Ther Adv Endocrinol Metab       Date:  2019-12-18       Impact factor: 3.565

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.